Novel omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis

Amit Sharma, Md Abdul Hye Khan, Scott P. Levick, Kin Sing Stephen Lee, Bruce D. Hammock, John D. Imig

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Cytochrome P450 (CYP) monooxygenases epoxidize the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid into novel epoxydocosapentaenoic acids (EDPs) that have multiple biological actions. The present study determined the ability of the most abundant EDP regioisomer, 19,20-EDP to reduce kidney injury in an experimental unilateral ureteral obstruction (UUO) renal fibrosis mouse model. Mice with UUO developed kidney tubular injury and interstitial fibrosis. UUO mice had elevated kidney hydroxyproline content and five-times greater collagen positive fibrotic area than sham control mice. 19,20-EDP treatment to UUO mice for 10 days reduced renal fibrosis with a 40%-50% reduction in collagen positive area and hydroxyproline content. There was a six-fold increase in kidney ∝-smooth muscle actin (∝-SMA) positive area in UUO mice compared to sham control mice, and 19,20-EDP treatment to UUO mice decreased ∝-SMA immunopositive area by 60%. UUO mice demonstrated renal epithelial-to-mesenchymal transition (EMT) with reduced expression of the epithelial marker E-cadherin and elevated expression of multiple mesenchymal markers (FSP-1, ∝-SMA, and desmin). Interestingly, 19,20-EDP treatment reduced renal EMT in UUO by decreasing mesenchymal and increasing epithelial marker expression. Overall, we demonstrate that a novel omega-3 fatty acid metabolite 19,20-EDP, prevents UUO-induced renal fibrosis in mice by reducing renal EMT.

Original languageEnglish (US)
Article number751
JournalInternational Journal of Molecular Sciences
Volume17
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Hydroxyproline
fibrosis
Ureteral Obstruction
metabolites
Omega-3 Fatty Acids
kidneys
fatty acids
Metabolites
Fatty acids
Collagen
mice
Fibrosis
Polyunsaturated fatty acids
Kidney
Desmin
Acids
Docosahexaenoic Acids
Cadherins
Mixed Function Oxygenases
Unsaturated Fatty Acids

Keywords

  • Epithelial-to-mesenchymal transition
  • Fatty acid epoxide
  • Omega-3 fatty acid
  • Renal fibrosis

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Spectroscopy
  • Inorganic Chemistry
  • Catalysis
  • Molecular Biology
  • Computer Science Applications

Cite this

Sharma, A., Khan, M. A. H., Levick, S. P., Lee, K. S. S., Hammock, B. D., & Imig, J. D. (2016). Novel omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis. International Journal of Molecular Sciences, 17(5), [751]. https://doi.org/10.3390/ijms17050751

Novel omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis. / Sharma, Amit; Khan, Md Abdul Hye; Levick, Scott P.; Lee, Kin Sing Stephen; Hammock, Bruce D.; Imig, John D.

In: International Journal of Molecular Sciences, Vol. 17, No. 5, 751, 01.05.2016.

Research output: Contribution to journalArticle

Sharma, A, Khan, MAH, Levick, SP, Lee, KSS, Hammock, BD & Imig, JD 2016, 'Novel omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis', International Journal of Molecular Sciences, vol. 17, no. 5, 751. https://doi.org/10.3390/ijms17050751
Sharma, Amit ; Khan, Md Abdul Hye ; Levick, Scott P. ; Lee, Kin Sing Stephen ; Hammock, Bruce D. ; Imig, John D. / Novel omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis. In: International Journal of Molecular Sciences. 2016 ; Vol. 17, No. 5.
@article{f5f738500b954927848158bd16d278da,
title = "Novel omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis",
abstract = "Cytochrome P450 (CYP) monooxygenases epoxidize the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid into novel epoxydocosapentaenoic acids (EDPs) that have multiple biological actions. The present study determined the ability of the most abundant EDP regioisomer, 19,20-EDP to reduce kidney injury in an experimental unilateral ureteral obstruction (UUO) renal fibrosis mouse model. Mice with UUO developed kidney tubular injury and interstitial fibrosis. UUO mice had elevated kidney hydroxyproline content and five-times greater collagen positive fibrotic area than sham control mice. 19,20-EDP treatment to UUO mice for 10 days reduced renal fibrosis with a 40{\%}-50{\%} reduction in collagen positive area and hydroxyproline content. There was a six-fold increase in kidney ∝-smooth muscle actin (∝-SMA) positive area in UUO mice compared to sham control mice, and 19,20-EDP treatment to UUO mice decreased ∝-SMA immunopositive area by 60{\%}. UUO mice demonstrated renal epithelial-to-mesenchymal transition (EMT) with reduced expression of the epithelial marker E-cadherin and elevated expression of multiple mesenchymal markers (FSP-1, ∝-SMA, and desmin). Interestingly, 19,20-EDP treatment reduced renal EMT in UUO by decreasing mesenchymal and increasing epithelial marker expression. Overall, we demonstrate that a novel omega-3 fatty acid metabolite 19,20-EDP, prevents UUO-induced renal fibrosis in mice by reducing renal EMT.",
keywords = "Epithelial-to-mesenchymal transition, Fatty acid epoxide, Omega-3 fatty acid, Renal fibrosis",
author = "Amit Sharma and Khan, {Md Abdul Hye} and Levick, {Scott P.} and Lee, {Kin Sing Stephen} and Hammock, {Bruce D.} and Imig, {John D.}",
year = "2016",
month = "5",
day = "1",
doi = "10.3390/ijms17050751",
language = "English (US)",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "5",

}

TY - JOUR

T1 - Novel omega-3 fatty acid epoxygenase metabolite reduces kidney fibrosis

AU - Sharma, Amit

AU - Khan, Md Abdul Hye

AU - Levick, Scott P.

AU - Lee, Kin Sing Stephen

AU - Hammock, Bruce D.

AU - Imig, John D.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Cytochrome P450 (CYP) monooxygenases epoxidize the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid into novel epoxydocosapentaenoic acids (EDPs) that have multiple biological actions. The present study determined the ability of the most abundant EDP regioisomer, 19,20-EDP to reduce kidney injury in an experimental unilateral ureteral obstruction (UUO) renal fibrosis mouse model. Mice with UUO developed kidney tubular injury and interstitial fibrosis. UUO mice had elevated kidney hydroxyproline content and five-times greater collagen positive fibrotic area than sham control mice. 19,20-EDP treatment to UUO mice for 10 days reduced renal fibrosis with a 40%-50% reduction in collagen positive area and hydroxyproline content. There was a six-fold increase in kidney ∝-smooth muscle actin (∝-SMA) positive area in UUO mice compared to sham control mice, and 19,20-EDP treatment to UUO mice decreased ∝-SMA immunopositive area by 60%. UUO mice demonstrated renal epithelial-to-mesenchymal transition (EMT) with reduced expression of the epithelial marker E-cadherin and elevated expression of multiple mesenchymal markers (FSP-1, ∝-SMA, and desmin). Interestingly, 19,20-EDP treatment reduced renal EMT in UUO by decreasing mesenchymal and increasing epithelial marker expression. Overall, we demonstrate that a novel omega-3 fatty acid metabolite 19,20-EDP, prevents UUO-induced renal fibrosis in mice by reducing renal EMT.

AB - Cytochrome P450 (CYP) monooxygenases epoxidize the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid into novel epoxydocosapentaenoic acids (EDPs) that have multiple biological actions. The present study determined the ability of the most abundant EDP regioisomer, 19,20-EDP to reduce kidney injury in an experimental unilateral ureteral obstruction (UUO) renal fibrosis mouse model. Mice with UUO developed kidney tubular injury and interstitial fibrosis. UUO mice had elevated kidney hydroxyproline content and five-times greater collagen positive fibrotic area than sham control mice. 19,20-EDP treatment to UUO mice for 10 days reduced renal fibrosis with a 40%-50% reduction in collagen positive area and hydroxyproline content. There was a six-fold increase in kidney ∝-smooth muscle actin (∝-SMA) positive area in UUO mice compared to sham control mice, and 19,20-EDP treatment to UUO mice decreased ∝-SMA immunopositive area by 60%. UUO mice demonstrated renal epithelial-to-mesenchymal transition (EMT) with reduced expression of the epithelial marker E-cadherin and elevated expression of multiple mesenchymal markers (FSP-1, ∝-SMA, and desmin). Interestingly, 19,20-EDP treatment reduced renal EMT in UUO by decreasing mesenchymal and increasing epithelial marker expression. Overall, we demonstrate that a novel omega-3 fatty acid metabolite 19,20-EDP, prevents UUO-induced renal fibrosis in mice by reducing renal EMT.

KW - Epithelial-to-mesenchymal transition

KW - Fatty acid epoxide

KW - Omega-3 fatty acid

KW - Renal fibrosis

UR - http://www.scopus.com/inward/record.url?scp=84969143046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969143046&partnerID=8YFLogxK

U2 - 10.3390/ijms17050751

DO - 10.3390/ijms17050751

M3 - Article

C2 - 27213332

AN - SCOPUS:84969143046

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 5

M1 - 751

ER -